Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Tascini

Showing results (81-90 of 345) with videos related to

Pageof 35
Sort By:
Infection|May 31, 2015
Breakthrough Lactobacillus rhamnosus GG bacteremia associated with probiotic use in an adult patient with severe active ulcerative colitis: case report and review of the literatureSimone Meini, Raffaele Laureano, Lucia Fani, et al.
Pharmacotherapy|August 7, 2025
Precision Daptomycin Dosing: Comparison of 3-, 2-, 1-, and 0-Concentration Sample StrategiesSimone Giuliano, Manjunath P Pai, Jacopo Angelini, et al.
Frontiers in Immunology|August 28, 2020
Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key?Simone Meini, Andrea Zanichelli, Rodolfo Sbrojavacca, et al.
Pharmaceutics|September 28, 2023
Meropenem PK/PD Variability and Renal Function: "We Go Together"Jacopo Angelini, Simone Giuliano, Sarah Flammini, et al.
Antimicrobial Agents and Chemotherapy|February 24, 2011
Case report of a successful treatment of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia and MRSA/vancomycin-resistant Enterococcus faecium cholecystitis by daptomycinCarlo Tascini, Antonello Di Paolo, Marialuisa Polillo, et al.
Antimicrobial Agents and Chemotherapy|June 27, 2018
TEM-184, a Novel TEM-Derived Extended-Spectrum β-Lactamase with Enhanced Activity against AztreonamAlessandra Piccirilli, Mariagrazia Perilli, Gianfranco Amicosante, et al.
Journal of Medical Virology|June 10, 2020
Higher levels of IL-6 early after tocilizumab distinguish survivors from nonsurvivors in COVID-19 pneumonia: A possible indication for deeper targeting of IL-6Luca Quartuccio, Arianna Sonaglia, Davide Pecori, et al.
Vascular Pharmacology|July 10, 2024
Studying exosome fingerprint in COVID 19 patients using MALDI-TOFDaniele Stefanizzi, Federica Caponnetto, Riccardo Del Sal, et al.
Scientific Reports|September 15, 2023
Risk of long COVID main symptoms after SARS-CoV-2 infection: a systematic review and meta-analysisZoe Marjenberg, Sean Leng, Carlo Tascini, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 18, 2026
A Comparative Evaluation of Aztreonam-Avibactam and Ceftazidime-Avibactam Plus Aztreonam for Infections Due to MBL-Producing EnterobacteralesSimone Giuliano, Chiara Moreal, Jacopo Angelini, et al.
Pageof 35

Showing results (81-90 of 345) with videos related to

Sort By:
Pageof 35
Infection|May 31, 2015
Breakthrough Lactobacillus rhamnosus GG bacteremia associated with probiotic use in an adult patient with severe active ulcerative colitis: case report and review of the literatureSimone Meini, Raffaele Laureano, Lucia Fani, et al.
Pharmacotherapy|August 7, 2025
Precision Daptomycin Dosing: Comparison of 3-, 2-, 1-, and 0-Concentration Sample StrategiesSimone Giuliano, Manjunath P Pai, Jacopo Angelini, et al.
Frontiers in Immunology|August 28, 2020
Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key?Simone Meini, Andrea Zanichelli, Rodolfo Sbrojavacca, et al.
Pharmaceutics|September 28, 2023
Meropenem PK/PD Variability and Renal Function: "We Go Together"Jacopo Angelini, Simone Giuliano, Sarah Flammini, et al.
Antimicrobial Agents and Chemotherapy|February 24, 2011
Case report of a successful treatment of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia and MRSA/vancomycin-resistant Enterococcus faecium cholecystitis by daptomycinCarlo Tascini, Antonello Di Paolo, Marialuisa Polillo, et al.
Antimicrobial Agents and Chemotherapy|June 27, 2018
TEM-184, a Novel TEM-Derived Extended-Spectrum β-Lactamase with Enhanced Activity against AztreonamAlessandra Piccirilli, Mariagrazia Perilli, Gianfranco Amicosante, et al.
Journal of Medical Virology|June 10, 2020
Higher levels of IL-6 early after tocilizumab distinguish survivors from nonsurvivors in COVID-19 pneumonia: A possible indication for deeper targeting of IL-6Luca Quartuccio, Arianna Sonaglia, Davide Pecori, et al.
Vascular Pharmacology|July 10, 2024
Studying exosome fingerprint in COVID 19 patients using MALDI-TOFDaniele Stefanizzi, Federica Caponnetto, Riccardo Del Sal, et al.
Scientific Reports|September 15, 2023
Risk of long COVID main symptoms after SARS-CoV-2 infection: a systematic review and meta-analysisZoe Marjenberg, Sean Leng, Carlo Tascini, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 18, 2026
A Comparative Evaluation of Aztreonam-Avibactam and Ceftazidime-Avibactam Plus Aztreonam for Infections Due to MBL-Producing EnterobacteralesSimone Giuliano, Chiara Moreal, Jacopo Angelini, et al.
Pageof 35